Diese Veranstaltung hat bereits stattgefunden

Kongress

Retina World Congress 2019

An event for ophthalmologists
FL 33316 Fort Lauderdale , USA
Veranstaltungsnummer: 25601
Zertifizierung: genehmigt
CME Max: 1
Kategorie:
Gebühren ab: 239,00 USD
verfügbare Plätze: unbegrenzt
Sprache: Englisch

 Zum Kalender hinzufügen
  • Datum
    21.03.2019, 08:00 - 24.03.2019, 12:00
    Veranstalter
    MCME Global, Inc.
    Kurzbeschreibung
    Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. Their biennial meeting is their main initiative and has brought together 150 faculty and 1,000 attendees from 32 U.S. states, 74 countries and 39 retina societies from around the globe. Again in 2019 to share research, innovations and ideas.
    Hinweis
    \r\nParticipants must complete an online evaluation to receive a CME Certificate documenting AMA PRA Category 1 Credit(s)™ earned for attending sessions.\r\n\r\nINTERNATIONAL NOTICE: This educational activity is designated for AMA PRA Category 1 Credit(s)™ for all US physicians. All physicians will receive a CME certificate and non-US physicians should contact their respective organizations for reciprocity of credit.
    Gebühren

    Fachärzte

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    839,00 USD

    Earlybird bis 15.01.2019
    739,00 USD
    Hinweis
    Retina Unplugged:

    "RWC Attendee – FREE!
    Non-attendee Physician – $325
    Non-attendee Resident – $125
    Non-attendee Corporate – $425"

    Social Reception:

    "RWC Attendee – FREE!
    Non-attendee rates coming soon"

    Ärzte/-innen in Weiterbildung

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    839,00 USD

    Earlybird bis 15.01.2019
    739,00 USD
    Hinweis
    Retina Unplugged:

    "RWC Attendee – FREE!
    Non-attendee Physician – $325
    Non-attendee Resident – $125
    Non-attendee Corporate – $425"

    Social Reception:

    "RWC Attendee – FREE!
    Non-attendee rates coming soon"

    Studenten/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    339,00 USD

    Earlybird bis 15.01.2019
    239,00 USD
    Hinweis
    Retina Unplugged:

    "RWC Attendee – FREE!
    Non-attendee Physician – $325
    Non-attendee Resident – $125
    Non-attendee Corporate – $425"

    Social Reception:

    "RWC Attendee – FREE!
    Non-attendee rates coming soon"

    Industriemitarbeiter/-innen

    Teilnehmer max.
    unbegrenzt

    Gebühren ab
    1.039,00 USD

    Earlybird bis 15.01.2019
    839,00 USD
    Hinweis
    Retina Unplugged:

    "RWC Attendee – FREE!
    Non-attendee Physician – $325
    Non-attendee Resident – $125
    Non-attendee Corporate – $425"

    Social Reception:

    "RWC Attendee – FREE!
    Non-attendee rates coming soon"

  • THURSDAY, MARCH 21  
         
      Ocular Oncology  
         
    1:10 pm – 1:17 pm Management of High-risk Choroidal Melanoma Carol L. Shields, MD

    1:17 pm – 1:24 pm

    Invisible Tumors or Giant Iris Melanocyte Jerry A. Shields, MD
    1:24 pm – 1:31 pm Using Imaging to Help Diagnose Ocular TumorsRubens N. Belfort, MD, PhD Rubens N. Belfort, MD, PhD

    1:31 pm – 1:38 pm

    Anti-VEGF Therapy for Radiation Retinopathy Prithvi Mruthyunjaya, MD, MHS
    1:38 pm – 1:45 pm Choroidal Nevus Risk Factors: Weighted Relevance Based on Molecular Prognostication  J. William Harbour, MD

    1:45 pm – 1:52 pm

    The Expanding Use of Ophthalmic Artery Chemosurgery Timothy G. Murray, MD, MBA
    1:52 pm – 1:59 pm Future Therapeutics for Ocular Oncology  Arun D. Singh, MDA

    1:59 pm – 2:06 pm

    Abstract Presentation  

    2:06 pm – 2:20 pm

    Panel Discussion: Surgical and Medical Management of Ocular Oncology Cases Moderator: Arun D. Singh, MD
         
      Macular Surgery  
         
    2:25 pm – 2:32 pm Pneumatic vs. Chemical Approaches to Vitreomacular Traction

    Speaker To Be Announced

    2:32 pm – 2:39 pm

    Ectopic Inner Foveal Layers in ERMs, Surgical Results

    Andrea Govetto, MD, PhD

    2:39 pm – 2:46 pm

    Submacular Irrigation for Large Macular Holes

    Mario J. Saravia, MD

    2:46 pm – 2:53 pm

    Development of a Deep Learning System for Digitally Enhanced Internal
    Limiting Membrane Peeling

    Kazuaki Kadonosono, MD, PhD

    2:53 pm – 3:00 pm

    Approach to Lamellar Macular Hole Repair 

    Yuki Morizane, MD, PhD

    3:00 pm – 3:07 pm

    Inverted ILM Flap Techniques and Indications 

    Jerzy Nawrocki, MD, PhD

    3:07 pm – 3:14 pm

    Abstract Presentation

     

    3:14 pm – 3:21 pm

    Autologous Tissue Transplantation for Macular Holes

    Tamer H. Mahmoud, MD, PhD

    3:21 pm – 3:28 pm

    Surgical Management of AMD in Anti-VEGF Era

    Cesare Marriotti, MD

    3:28 pm – 3:35 pm

    Optic Pits 

    Leandro C. Zacharias, MD, PhD

    3:35 pm – 3:42 pm

    Managing Myopic Foveoschisis: Surgery or Observation

    Yusuke Oshima, MD, PhD

    3:42 pm – 3:49 pm

    Abstract Presentation

     

    3:49 pm – 3:56 pm

    Abstract Presentation

     

    3:56 pm – 4:15 pm

    Panel Discussion  Moderator: Gaurav K. Shah, MD
         
      Medical Retina: Retinal Vein Occlusion  
         

    4:20 pm – 4:27 pm

    Effect of Anti-VEGF and Steroids Treatment on Retinal Non-perfusion

    Jorge C. P. Rocha, MD, PhD

    4:27 pm – 4:34 pm

    SCORE-2 Results and Implications to Clinical Practice

    Michael S. Ip, MD

    4:34 pm – 4:41 pm

    Addressing RVO with Corticosteroids

    Baruch D. Kuppermann, MD, PhD

    4:41 pm – 4:48 pm

    Comparative Studies of Treatments for RVO: LEAVO Study Results

     

    4:48 pm – 4:55 pm

    Abstract Presentation

     

    4:55 pm – 5:02 pm

    Abstract Presentation

     

    5:02 pm – 5:09 pm

    Abstract Presentation

     
    5:09 pm – 5:16 pm

    Abstract Presentation

     

    5:16 pm – 5:45 pm

    Panel Discussion Moderator: Marcio B. Nehemy, MD, PhD
         
    FRIDAY, March 22    
         
      Surgical Technology  
         

    8:00 am – 8:07 am

    Scleral Fixation of In-the-bag Luxated or Subluxated IOLs

    Martin Charles, MD

    8:07 am – 8:14 am

    Intraoperative OCT: Where Do We Stand?

     

    8:14 am – 8:21 am

    Hybrid Wide-angle Viewing and Endoscopic Vitrectomy Using a
    3D Visualization System

    Mihori Kita, MD, PhD

    8:21 am – 8:28 am Science of 3D Visualization Systems

    David R. Chow, MD, FRCSC

    8:28 am – 8:35 am

    Advancements in Visualization in VR Surgery

    Khalid Al-Sabti, MD, FRCSC

    8:35 am – 8:56 am

    Panel Discussion: Instrumentation in the OR Moderator: David R. Chow, MD, FRCSC
         
      Retinal Detachment Surgery  
         

    9:00 am – 9:07 am

    Temporal Keratoprothesis and Vitrectomy

    Andres Bastien, MD

    9:07 am – 9:14 am

    Chandelier Illumination for Scleral Buckling

    Nur Acar Gocgil, MD, Prof, FEBO

    9:14 am – 9:21 am

    Management of Retinal Detachment in Pediatric Age

    Ehab N. El Rayes, MD, PhD

    9:21 am – 9:28 am

    The Art and Science of YAG Vitreolysis

    Kirk H. Packo, MD

    9:28 am – 9:35 am

    Retinal Detachment from Macular Hole

    Marcio B. Nehemy, MD, PhD

    9:35 am – 10:02 am

    ILM Peeling During Retinal Detachment Surgery: Is It Necessary?

    Ezequiel Rosendi, MD

    10:02 am – 10:09 am

    Abstract Presentation

     

    10:09 am – 10:16 am

    Abstract Presentation

     
         
      Imaging  
         

    10:35 am – 10:42 am

    Artificial Intelligence in OCT Imaging 

    Javier Zarranz-Ventura, MD, PhD, FEBO

    10:42 am – 10:49 am

    Artificial Intelligence and Choroidal Imaging

    Taiji Sakamoto, MD, PhD

    10:49 am – 10:56 am

    Angiogenic Biomarkers in Neovascular AMD 

    Luiz H. Lima, MD

    10:56 am – 11:03 am

    Quantitative Comparison of UWF Imaging Devices 

    Ajay E. Kuriyan, MD, MS

    11:03 am – 11:10 am

    How Optical Coherence Angiography Changes My Practice

    Miho Nozaki, MD, PhD

    11:10 am – 11:17 am

    Agreement between OCT Angiography and FA/ICG in Neovascular AMD

    Nadia K. Waheed, MD, MPH

    11:17 am – 11:24 am

    Mac Tel 2: A Multimodal Imaging Journey

    Lihteh Wu, MD

    11:24 am – 11:31 am

    OCT Angiography in CNV: Are There Parameters that
    Predict Anti-VEGF Treatment Frequency?

    Amani A. Fawzi, MD

    11:31 am – 11:38 am

    Multimodal Imaging in Polypoidal Choriodovasculopathy

    Seung-Young Yu, MD, PhD

    11:38 am – 11:45 am

    Comparison of Ultra-widefield Imaging Devices

    Claudia Acosta, MD

         

    1:15 pm – 1:22 pm

    Ultra-widefield Imaging and Diabetic Retinopathy

    Justis P. Ehlers, MD

    1:22 pm – 1:29 pm

    Ultra-widefield OCTA and Retinal Vein Occlusion

    Kasra A. Rezaei, MD

    1:29 pm – 1:36 pm

    Adaptive Optics Imaging in a Retina Practice

    Mina M. Chung, MD

    1:36 pm – 1:43 pm

    Clinical Optimization of OCT-Angiography in Routine Practice

    Netan Choudhry, MD, FRCSC

    1:43 pm – 1:50 pm

    Multimodal Retinal Imaging for Alzheimer’s Disease 

    Sharon Fekrat, MD

    1:50 pm – 1:57 pm

    Abstract Presentation

     

    1:57 pm – 2:10 pm

    Panel Discussion  Moderator: Jay S. Duker, MD
         
      Age-related Macular Degeneration  
         

    2:15 pm – 2:22 pm

    Drusen Ooze: New Hypothesis for Geographic Atrophy Growth

     

    2:22 pm – 2:29 pm

    AMD, Genetic Testing and AREDS Supplements

    Carl C. Awh, MD

    2:29 pm – 2:36 pm

    Prevention of Exudative AMD in High Risk Eyes

    Sumit P. Shah, MD

    2:36 pm – 2:43 pm

    Geographic Atrophy Associated with AMD, Incidence and
    Factors Influencing Growth Rate

    Nancy Holenkamp, MD

    2:43 pm – 2:50 pm

    C3 Complement Inhibition for the Reduction of Growth in Geographic Atrophy

    Nathan C. Steinle, MD

    2:50 pm – 2:57 pm

    Impact of Genetics on AMD Conversion and Response

     

    2:57 pm – 3:04 pm

    Gene Therapy for Dry AMD  Elias Reichel, MD

    3:04 pm – 3:11 pm

    Emerging Therapies on Dry AMD

    Paolo Lanzetta, MD

         
     

    EXUDATIVE AMD

     
         

    3:11 pm – 3:18 pm

    Nonexudative Neovascular AMD: What Is It?

    Daniela Ferrara, MD, MSc, PhD

    3:18 pm – 3:25 pm

    Evaluating the Social Costs of Blindness from AMD

    Andrew A. Moshfeghi, MD, MBA

    3:25 pm – 3:32 pm

    Real-world Anti-VEGF Treatment for AMD

    Patricio P. Schlottmann, MD

         

    3:52 pm – 3:59 pm

    Angiopoietin Pathway in Neovascular Diseases

    Peter K. Kaiser, MD

    3:59 pm – 4:06 pm Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Exudative AMD 

    Carl D. Regillo, MD

    4:06 pm – 4:13 pm

    Gene Therapy for Exudative AMD

     

    4:13 pm – 4:20 pm

    A Comparison of Brolucizumab and Afibercept in Neovascular Age-related
    Macular Degeneration: Important Subanalyses 

    Pravin U. Dugel, MD

    4:20 pm – 4:27 pm

    Stem Cell Therapy for AMD

     

    4:27 pm – 4:34 pm

    Emerging Therapies for Exudative AMD

    David S. Boyer, MD

    4:34 pm – 4:41 pm

    Abstract Presentation

     

    4:41 pm – 4:48 pm

    Abstract Presentation

     

    4:48 pm – 5:12 pm

    Panel Discussion  Moderator: Rishi P. Singh, MD
         
      Diabetic Vitrectomy  
         

    5:12 pm – 5:19 pm

    Intravitreal Anti-VEGF as an Adjunct to Vitrectomy Surgery for Diabetic Tractional
    Retinal Detachment 

    J. Fernando Arevalo, MD, FACS

    5:19 pm – 5:26 pm

    Vitrectomy for Diabetic Macular Edema

    Jay Chhablani, MD

    5:26 pm – 5:33 pm

    Role of Patient Compliance in the Development of Sight Threatening Diabetic Retinopathy

    Shwu-Jiuan Sheu, MD

    5:33 pm – 5:40 pm

    All-probe Vitrectomy Dissection Techniques for Diabetic Tractional Retinal Detachments:
    Lift and Shave

    Maria H. Berrocal, MD

    5:40 pm – 5:47 pm

    3D Surgery for Diabetic Surgery

    Marco Mura, MD

    5:47 pm – 5:54 pm

    Advanced Maneuvers in Proliferative Diabetic Surgery 

    Andre V. Gomes, MD, PhD

    5:54 pm – 6:01 pm

    Steroid Drops after Vitreoretinal Surgery: Is It Time To Go Drop-less?

    John S. Pollack, MD

    6:01 pm – 6:08 pm

    Abstract Presentation

     

    6:08 pm – 6:30 pm

    Panel Discussion  Moderator: Kourous A. Rezaei, MD
         
    SATURDAY, March 23    
         
      Trauma and Proliferative Vitreoretinopathy Surgery  
         

    8:00 am – 8:07 am

    Re-examination of the Role of Relaxing Retinotomy in PVR Detachment Repair

    Grazia Pertile, MD

    8:07 am – 8:14 am

    Severe Trauma Cases: Pearls and Tricks

    Carl C. Claes, MD

    8:14 am – 8:21 am

    Ocular Trauma: New Updates

    Sundaram Natarajan, MD

    8:21 am – 8:28 am

    Pharmaceutical Management of PVR

    Demetrios G. Vavvas, MD, PhD

    8:28 am – 8:35 am

    Is Scleral Buckling Necessary?

    Gaurav K. Shah, MD

    8:35 am – 8:42 am

    Management of Subretinal Perfluorocarbon Liquid

    Leonardo B. Oliveira, MD

    8:42 am – 8:49 am

    Use Perfluorocarbon as a Tamponade Agent

    Stanislao Rizzo, MD

    8:49 am – 8:56 am

    Treatment of Persistent Hypotony in PVR Eyes 

    Tarek S. Hassan, MD

    8:56 am – 9:03 am

    Strategy for the Primary PVR Surgery

    Motohiro Kamei, MD, PhD

    9:03 am – 9:10 am

    Abstract Presentation

     

    9:10 am – 9:17 am

    Abstract Presentation

     

    9:17 am – 9:40 am

    Panel Discussion  Moderator: Moderator: Nur Acar Gocgil, MD
         
      Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy  
         

    10:00 am – 10:07 am

    Dual Approach for DME: Findings from Faricimab

    Dilsher S. Dhoot, MD

    10:07 am – 10:14 am

    Identifying Eyes that will Develop Vision Threatening Retinopathy

    Patricia Udaondo, MD

    10:14 am – 10:21 am

    Long-term Outcomes of Anti-VEGF Therapy for Proliferative Diabetic Retinopathy:
     Year 5 Protocol S Outcomes

    Jeffrey G. Gross, MD

    10:21 am – 10:28 am

    The Value of Treating Non-proliferative Diabetic Retinopathy

    Lloyd W. Clark, MD

    10:28 am – 10:35 am

    Rescuing those with Poor Anti-VEGF Treatment Response

    Daniel F. Martin, MD

    10:35 am – 10:42 am

    Long-term Anti-VEGF Treatment Outcomes

     

    10:42 am – 10:49 am

    Matching Diabetic Choroidopathy to Retinopathy: A Classification System of OCT Findings

    Lilianne G. Duarte, MD, PgD

    10:49 am – 10:56 am

    Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema

     

    10:56 am – 11:03 am

    Peripheral Diabetic Retinopathy as a Risk Factor for the Progression of Diabetic Retinopathy

     

    11:03 am – 11:10 am

    Integrin Antagonism for DME

    Hugo Quiroz-Mercado, MD

    11:10 am – 11:17 am

    Kallikrein Inhibitors for DME

    Victor H. Gonzalez, MD

    11:17 am – 11:24 am

    Abstract Presentation

     

    11:24 am – 11:31 am

    Abstract Presentation

     

    11:31 am – 11:45 am

    Panel Discussion Moderator: To Be Announced
         
      Controversies and Debates  
         
    1:15 pm – 1:21 pm Is Digital Visualization Surgery Necessary in Practice?  Pro: Flavio A. Rezende, MD, PhD
    Con: Raja Narayanan, MD, MBA

    1:21 pm – 1:26 pm

    Question & Answer

     

    1:26 pm – 1:32 pm

    Is It Necessary to Limit Internal Membrane Flaps in Macular Hole Surgery? Pro: Anthanasios Nikolakopoulos, MD
    Con: John W. Kitchens, MD

    1:32 pm – 1:37 pm

    Question & Answer

     

    1:37 pm – 1:43 pm

    Is Intraoperative OCT Ready for Prime Time?  Pro: Susanne Binder, MD
    Con: Magno A. Ferreira, MD, MsC, MBA, PhD

    1:43 pm – 1:48 pm

    Question & Answer

     

    1:48 pm – 1:54 pm

    Is Scleral Buckling Still a Useful Technique?  Pro: Marcos P. Ávila, MD
    Con: Fabio Patelli, MD

    1:54 pm – 1:59 pm

    Question & Answer

     

    1:59 pm – 2:05 pm

    What is the First Line of Treatment for Center Involved DME?  Steroids: Laurent Kodjikian, MD, PhD, FEBO
    Anti-VEGF: Marcelo Zas, MD, PhD

    2:05 pm – 2:10 pm

    Question & Answer

     

    2:10 pm – 2:16 pm

    Should Vitrectomy be the Primary Therapy for Endophthalmitis?  Pro: Ferenc Kuhn, MD, PhD
    Con: William E. Smiddy, MD

    2:16 pm – 2:21 pm

    Question & Answer

     

    2:21 pm – 2:27 pm

    What is the First Line of Treatment for Chronic CSCR?  PDT: Speaker To Be Announced
    Mineralocorticoid-receptor Antagonists:
    Francine Behar-Cohen, MD, PhD
    Micropulse Laser: Jose A. Roca, MD

    2:27 pm – 2:35 pm

    Question & Answer

     
         
    2:55 pm – 3:01 pm What is the First Line of Treatment for PCV? PDT plus Anti-VEGF: Gregg T. Kokame, MD
    Anti-VEGF Monotherapy: Speaker To Be Announced

    3:01 pm – 3:06 pm

    Question & Answer

     

    3:06 pm – 3:12 pm

    Is Telemedicine for Ophthalmology Evaluations Ready for Prime Time?  Pro: Alexandre Taleb, MD, PhD
    Con: Francisco Rodrigues, MD

    3:12 pm – 3:17 pm

    Question & Answer

     

    3:17 pm – 3:23 pm

    Is Pneumatic Retinopexy Useful?  Pro: Rajeev H. Muni, MD, MSc, FRCSC
    Con: Michael Kapusta, MD

    3:23 pm – 3:30 pm

    Question & Answer

     
         
      RETINAWS  
         
    3:30 pm – 4:30 pm Join us for a video-oriented surgical course where we’ll discuss complex
    vitreoretinal surgery, rare surgical cases and unique surgical techniques.
     
         
      Early Career Session  
         
    4:30 pm – 5:30 pm Social Media for Collaboration: Young Retina Forum Survey Results Hemang K. Pandya, MD
      How to Gain an Audience Outside of the Podium Jayanth Sridhar, MD
      Getting Started with Clinical Research in Private Practice Chirag Jhaveri, MD
      Choose Your Own Adventure: Case Presentations Sumit Sharma, MD; Eduardo Uchiyama, MD
      International Collaboration: Panel Discussion Jorge A. Fortun, MD; Chirag Jhaveri, MD;
    Mitul Mehta, MD, MS; Raja Narayanan, MBBS, 
    MS; Hemang K. Pandya, MD; Sumit Sharma, MD
         
    SUNDAY, March 24    
         
      Pediatrics, Pediatric Surgery, Gene Therapy and Upcoming Technologies  
         

    8:00 am – 8:07 am

    New Therapy Approaches for Retinopathy of Prematurity 

    Darius M. Moshfeghi, MD

  • Fort Lauderdale Marriott Harbor Beach Resort & Spa

    MCME Global, Inc.
    Meeting Services Coordinator: Yolanda Anderson
    2550 Fifth Ave, Ste 145
    US - CA 92103 San Diego
    Tel.: +1 619 344 6971
    Fax: +1 619 564 7290

  •  

    Registration required. Please contact the organizer for further information.